Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 julio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention. Results From the PARIS Registry

Usman Baber, MD, MSa; George Dangas, MD, PhDa; Jaya Chandrasekhar, MBBSa; Samantha Sartori, PhDa; Philippe Gabriel Steg, MDb; David J. Cohen, MD, MScc; Gennaro Giustino, MDa; Cono Ariti, MScd; Bernhard Witzenbichler, MDe; Timothy D. Henry, MDf; Annapoorna S. Kini, MDa; Mitchell W. Krucoff, MDg; C. Michael Gibson, MDh; Alaide Chieffo, MDi; David J. Moliterno, MDj; Giora Weisz, MDk; Antonio Colombo, MDi; Stuart Pocock, PhDd; Roxana Mehran, MDa

Objectives: The aim of this study was to examine the independent associations between actionable bleeding (AB) and coronary thrombotic events (CTE) on mortality risk after percutaneous coronary intervention (PCI).

01 julio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification. Results From the First Multicenter Global Registry

Mayra Guerrero, MDa; Danny Dvir, MDb; Dominique Himbert, MDc; Marina Urena, MDc; Mackram Eleid, MDd; Dee Dee Wang, MDe; Adam Greenbaum, MDe; Vaikom S. Mahadevan, MBBS, MDf; David Holzhey, MD, PhDg; Daniel O’Hair, MDh; Nicolas Dumonteil, MDi; Josep Rodés-Cabau, MDj; Nicolo Piazza, MDk; Jose H. Palma, MD, PhDl; Augustin DeLago, MDm; Enrico Ferrari, MDn; Adam Witkowski, MD, PhDo; Olaf Wendler, MD, PhDp; Ran Kornowski, MDq; Pedro Martinez-Clark, MDr; Daniel Ciaburri, MDs; Richard Shemin, MDt; Sami Alnasser, MDu; David McAllister, DOv; Martin Bena, MDw; Faraz Kerendi, MDx; Gregory Pavlides, MDy; Jose J. Sobrinho, MDz; Guilherme F. Attizzani, MDaa; Isaac George, MDbb; George Nickenig, MDcc; Amir-Ali Fassa, MDdd; Alain Cribier, MDee; Vinnie Bapat, MDff; Ted Feldman, MDa; Charanjit Rihal, MDd; Alec Vahanian, MDc; John Webb, MDb; William O’Neill, MDe

Objectives: This study sought to evaluate the outcomes of the early experience of transcatheter mitral valve replacement (TMVR) with balloon-expandable valves in patients with severe mitral annular calcification (MAC) and reports the first large series from a multicenter global registry.

01 julio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices

Konstantinos C. Koskinas, MD, MSca; Samera Shakir, MDa; Máté Fankhauser, MSa; Fabian Nietlispach, MDb; Adrian Attinger-Toller, MDb; Aris Moschovitis, MDa; Peter Wenaweser, MDa; Thomas Pilgrim, MDa; Stefan Stortecky, MDa; Fabien Praz, MDa; Lorenz Räber, MDa; Stephan Windecker, MDa; Bernhard Meier, MDa; Steffen Gloekler, MDa

Objectives: The aim of this study was to assess predictors of adverse 1-week outcomes and determine the effect of left atrial appendage (LAA) morphology following LAA closure (LAAC) with Amplatzer devices.

01 julio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Sequential Proximal Optimizing Technique in Provisional Bifurcation Stenting With Everolimus-Eluting Bioresorbable Vascular Scaffold. Fractal Coronary Bifurcation Bench for Comparative Test Between Absorb and XIENCE Xpedition

François Derimay, MD, MSca; Géraud Souteyrand, MD, MScb; Pascal Motreff, MD, PhDb; Patrice Guerin, MD, PhDc; Paul Pilet, B Engc; Jacques Ohayon, PhDd; Olivier Darremont, MDe; Gilles Rioufol, MD, PhDa; Gérard Finet, MD, PhDa

Objectives: The aim of this fractal bifurcation bench study was to compare provisional bifurcation stenting with a “re-POT” sequence, comprising a proximal optimizing technique (POT), side branch inflation, and final POT, between a bioresorbable vascular scaffold (BVS) and a metallic stent.

07 julio 2016

EUROPEAN HEART JOURNAL. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials

George C.M. Siontis, Fabien Praz, Thomas Pilgrim, Dimitris Mavridis, Subodh Verma, Georgia Salanti, Lars Søndergaard, Peter Jüni, Stephan Windecker

Aims: In view of the currently available evidence from randomized trials, we aimed to compare the collective safety and efficacy of transcatheter aortic valve implantation (TAVI) vs. surgical aortic valve replacement (SAVR) across the spectrum of risk and in important subgroups.

18 enero 2016

EUROPEAN HEART JOURNAL. Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunction

Zainab Samad, Amit N. Vora, Allison Dunning, Phillip J. Schulte, Linda K. Shaw, Fawaz Al-Enezi, Mads Ersboll, Robert W. McGarrah III, John P. Vavalle, Svati H. Shah, Joseph Kisslo, Donald Glower, J. Kevin Harrison, Eric J. Velazquez

Aims: We aimed to determine the frequency of aortic valve surgery (AVR) with or without coronary artery bypass grafting (CABG), among patients with moderate/severe aortic stenosis (AS) and left ventricular systolic dysfunction (LVSD), and its relationship with survival.

15 septiembre 2015

EUROPEAN HEART JOURNAL. The comparative efficacy of bivalirudin is markedly attenuated by use of radial access: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium

Emily Perdoncin, Milan Seth, Simon Dixon, Louis Cannon, Akshay Khandelwal, Arthur Riba, Shukri David, David Wohns, Hitinder Gurm

Aim: The purpose of our study was to evaluate the relative impact of bivalirudin on bleeding outcomes associated with trans-radial interventions (TRI) in real world practice.

08 mayo 2016

EUROPEAN HEART JOURNAL. Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study

Miles W. Behan, Niels R. Holm, Adam J. de Belder, James Cockburn, Andrejs Erglis, Nicholas P. Curzen, Matti Niemelä, Keith G. Oldroyd, Kari Kervinen, Indulis Kumsars, Paal Gunnes, Rodney H. Stables, Michael Maeng, Jan Ravkilde, Jan Skov Jensen, Evald H. Christiansen, Nina Cooter, Terje K. Steigen, Saila Vikman, Leif Thuesen, Jens Flensted Lassen, David Hildick-Smith

Aims: Randomized trials of coronary bifurcation stenting have shown better outcomes from a simple (provisional) strategy rather than a complex (planned two-stent) strategy in terms of short-term efficacy and safety. Here, we report the 5-year all-cause mortality based on pooled patient-level data from two large bifurcation coronary stenting trials with similar methodology: the Nordic Bifurcation Study (NORDIC I) and the British Bifurcation Coronary Study: old, new, and evolving strategies (BBC ONE).

24 mayo 2016

CIRCULATION. Obstructive Sleep Apnea and Cardiovascular Events After Percutaneous Coronary Intervention

Chi-Hang Lee, Rishi Sethi, Ruogu Li, Hee-Hwa Ho, Thet Hein, Man-Hong Jim, Germaine Loo, Chieh-Yang Koo, Xiao-Fei Gao, Sharad Chandra, Xiao-Xiao Yang, Sofia F. Furlan, Zhen Ge, Ajeya Mundhekar, Wei-Wei Zhang, Carlos Henrique G. Uchôa, Rajiv Bharat Kharwar, Po-Fun Chan, Shao-Liang Chen, Mark Y. Chan, Arthur Mark Richards, Huay-Cheem Tan, Thun-How Ong, Glenn Roldan, Bee-Choo Tai, Luciano F. Drager and Jun-Jie Zhang

Background: There is a paucity of data from large cohort studies examining the prognostic significance of obstructive sleep apnea (OSA) in patients with coronary artery disease. We hypothesized that OSA predicts subsequent major adverse cardiac and cerebrovascular events (MACCEs) in patients undergoing percutaneous coronary intervention.

07 junio 2016

CIRCULATION. Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial

Bijoy K. Menon, Tolulope T. Sajobi, Yukun Zhang, Jeremy L. Rempel, Ashfaq Shuaib, John Thornton, David Williams, Daniel Roy, Alexandre Y. Poppe, Tudor G. Jovin, Biggya Sapkota, Blaise W. Baxter, Timo Krings, Frank L. Silver, Donald F. Frei, Christopher Fanale, Donatella Tampieri, Jeanne Teitelbaum, Cheemun Lum, Dar Dowlatshahi, Muneer Eesa, Mark W. Lowerison, Noreen R. Kamal, Andrew M. Demchuk, Michael D. Hill and Mayank Goyal

Background: The Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) trial used innovative imaging and aggressive target time metrics to demonstrate the benefit of endovascular treatment in patients with acute ischemic stroke. We analyze the impact of time on clinical outcome and the effect of patient, hospital, and health system characteristics on workflow within the trial.

01 mayo 2016

JACC. Outcomes in Moderate Mixed Aortic Valve Disease. Is it Time for a Paradigm Shift?

Alexander C. Egbe, MD, MPH; Sushil A. Luis, MBBS; Ratnasari Padang, MBBS, PhD; Carole A. Warnes, MD

Background: A direct comparison of outcomes between moderate mixed aortic valve disease (MAVD) and isolated aortic stenosis (AS) or aortic regurgitation (AR) has not been performed, making evidence-based recommendations difficult in patients with MAVD.

01 mayo 2016

JACC. Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement

Suzanne J. Baron, MD, MSca; Suzanne V. Arnold, MD, MHAa; Howard C. Herrmann, MDb; David R. Holmes, Jr., MDc; Wilson Y. Szeto, MDb; Keith B. Allen, MDa; Adnan K. Chhatriwalla, MDa; Sreekaanth Vemulapali, MDd; Sean O’Brien, PhDd; Dadi Dai, PhDd; David J. Cohen, MD, MSca

Background: In patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR), studies have suggested that reduced left ventricular (LV) ejection fraction (LVEF) and low aortic valve gradient (AVG) are associated with worse long-term outcomes. Because these conditions commonly coexist, the extent to which they are independently associated with outcomes after TAVR is unknown.

01 agosto 2016

JACC. 1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease. The PLATFORM Study

Pamela S. Douglas, MDa; Bernard De Bruyne, MDb; Gianluca Pontone, MDc; Manesh R. Patel, MDa; Bjarne L. Norgaard, MDd; Robert A. Byrne, MB BChe; Nick Curzen, BMf; Ian Purcell, MDg; Matthias Gutberlet, MDh; Gilles Rioufol, MDi; Ulrich Hink, MDj; Herwig Walter Schuchlenz, MDk; Gudrun Feuchtner, MDl; Martine Gilard, MDm; Daniele Andreini, MDc; Jesper M. Jensen, MDd; Martin Hadamitzky, MDe; Karen Chiswell, PhDa; Derek Cyr, PhDa; Alan Wilk, BSn; Furong Wang, MDn; Campbell Rogers, MDn; Mark A. Hlatky, MDo

Background: Coronary computed tomographic angiography (CTA) plus estimation of fractional flow reserve using CTA (FFRCT) safely and effectively guides initial care over 90 days in patients with stable chest pain. Longer-term outcomes are unknown.

01 julio 2016

JACC. Percutaneous Intervention for Myocardial Infarction After Noncardiac Surgery. Patient Characteristics and Outcomes

Akhil Parashar, MDa; Shikhar Agarwal, MD, MPHb; Amar Krishnaswamy, MDb; Karan Sud, MDb; Kanhaiya L. Poddar, MBBSb; Mehak Bassi, MBBSa; Stephen Ellis, MDb; E. Murat Tuzcu, MDb; Venu Menon, MDb; Samir R. Kapadia, MDb

Background: Few studies have explored percutaneous coronary intervention (PCI) in perioperative myocardial infarction (PMI), even though PMI is a major cause of mortality in patients undergoing urgent/emergent noncardiac surgery.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.